Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 20 | 2019 | 1430 | 1.290 |
Why?
|
Anti-Bacterial Agents | 34 | 2021 | 7477 | 1.020 |
Why?
|
Oxazolidinones | 10 | 2007 | 98 | 1.000 |
Why?
|
Acetamides | 10 | 2007 | 259 | 0.920 |
Why?
|
Vancomycin Resistance | 10 | 2007 | 125 | 0.860 |
Why?
|
Drug Resistance, Bacterial | 11 | 2009 | 1063 | 0.850 |
Why?
|
Vancomycin | 15 | 2018 | 506 | 0.810 |
Why?
|
Azithromycin | 2 | 2021 | 201 | 0.810 |
Why?
|
Staphylococcal Infections | 15 | 2017 | 1398 | 0.760 |
Why?
|
Gram-Positive Bacterial Infections | 9 | 2011 | 342 | 0.750 |
Why?
|
Hydroxychloroquine | 2 | 2021 | 426 | 0.660 |
Why?
|
Abscess | 3 | 2016 | 606 | 0.560 |
Why?
|
RNA, Ribosomal, 23S | 7 | 2007 | 54 | 0.530 |
Why?
|
Trimethoprim | 1 | 2016 | 79 | 0.520 |
Why?
|
Sulfadoxine | 1 | 2016 | 47 | 0.520 |
Why?
|
Long QT Syndrome | 1 | 2020 | 472 | 0.510 |
Why?
|
Skin Diseases, Bacterial | 1 | 2016 | 65 | 0.500 |
Why?
|
Bacteriological Techniques | 4 | 2017 | 277 | 0.480 |
Why?
|
Methicillin Resistance | 10 | 2006 | 198 | 0.480 |
Why?
|
Bacteremia | 6 | 2019 | 986 | 0.470 |
Why?
|
Enterococcus faecium | 7 | 2003 | 101 | 0.470 |
Why?
|
Enterococcus | 6 | 2004 | 159 | 0.460 |
Why?
|
Candida | 2 | 2017 | 173 | 0.420 |
Why?
|
Antibiotic Prophylaxis | 4 | 2019 | 640 | 0.420 |
Why?
|
Staphylococcus | 3 | 2014 | 146 | 0.400 |
Why?
|
Prosthesis-Related Infections | 4 | 2018 | 497 | 0.390 |
Why?
|
Gemella | 1 | 2011 | 4 | 0.390 |
Why?
|
Blood | 3 | 2010 | 599 | 0.380 |
Why?
|
Drainage | 1 | 2016 | 1183 | 0.340 |
Why?
|
Anti-Infective Agents | 7 | 2018 | 983 | 0.340 |
Why?
|
Microbial Sensitivity Tests | 21 | 2014 | 1967 | 0.320 |
Why?
|
Bacterial Proteins | 9 | 2010 | 3840 | 0.310 |
Why?
|
Penicillins | 5 | 2014 | 406 | 0.300 |
Why?
|
beta-Lactamases | 5 | 2019 | 307 | 0.300 |
Why?
|
Sinusitis | 1 | 2017 | 997 | 0.290 |
Why?
|
Sweet Syndrome | 1 | 2008 | 56 | 0.290 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1668 | 0.280 |
Why?
|
Cross Infection | 9 | 2017 | 1426 | 0.280 |
Why?
|
Mycobacterium | 1 | 2009 | 252 | 0.280 |
Why?
|
Genes, rRNA | 2 | 2004 | 73 | 0.280 |
Why?
|
Enterococcus faecalis | 5 | 2004 | 244 | 0.280 |
Why?
|
Fluoroquinolones | 5 | 2021 | 309 | 0.260 |
Why?
|
Equipment Contamination | 2 | 2017 | 183 | 0.250 |
Why?
|
Syphilis | 1 | 2008 | 243 | 0.240 |
Why?
|
Methicillin | 2 | 2003 | 62 | 0.240 |
Why?
|
Osteoarthritis | 1 | 2011 | 1072 | 0.220 |
Why?
|
Trans-Activators | 2 | 2003 | 2857 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.210 |
Why?
|
Mastitis | 2 | 2013 | 42 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Clostridium Infections | 2 | 2019 | 562 | 0.200 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2017 | 704 | 0.190 |
Why?
|
Cefazolin | 2 | 2019 | 95 | 0.190 |
Why?
|
Pacemaker, Artificial | 2 | 2018 | 828 | 0.190 |
Why?
|
Drug Resistance, Microbial | 6 | 2001 | 830 | 0.190 |
Why?
|
DNA, Ribosomal | 3 | 2011 | 300 | 0.190 |
Why?
|
Sterilization | 2 | 2017 | 132 | 0.180 |
Why?
|
Candidiasis | 2 | 2017 | 367 | 0.180 |
Why?
|
HIV | 1 | 2008 | 1597 | 0.180 |
Why?
|
Gram-Negative Bacteria | 2 | 2004 | 275 | 0.170 |
Why?
|
Nafcillin | 1 | 2019 | 23 | 0.160 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1546 | 0.160 |
Why?
|
Genes, Bacterial | 5 | 2004 | 1076 | 0.150 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 15 | 0.150 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.140 |
Why?
|
Ethylene Oxide | 1 | 2017 | 28 | 0.140 |
Why?
|
Equipment Reuse | 1 | 2017 | 45 | 0.140 |
Why?
|
Diabetic Foot | 1 | 2021 | 382 | 0.140 |
Why?
|
Duodenoscopes | 1 | 2017 | 43 | 0.140 |
Why?
|
Defibrillators, Implantable | 2 | 2017 | 1498 | 0.140 |
Why?
|
DNA, Bacterial | 4 | 2011 | 1478 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 649 | 0.130 |
Why?
|
beta-Lactams | 2 | 2018 | 158 | 0.130 |
Why?
|
Daptomycin | 2 | 2007 | 71 | 0.130 |
Why?
|
Streptococcus pneumoniae | 2 | 2004 | 764 | 0.130 |
Why?
|
Microbiological Techniques | 1 | 2017 | 97 | 0.130 |
Why?
|
Disinfectants | 1 | 2017 | 129 | 0.130 |
Why?
|
Sequence Analysis, DNA | 6 | 2011 | 4786 | 0.130 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6316 | 0.130 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2015 | 50 | 0.130 |
Why?
|
Disinfection | 1 | 2017 | 207 | 0.120 |
Why?
|
Mucositis | 1 | 2015 | 108 | 0.120 |
Why?
|
Enterobacter | 2 | 2005 | 44 | 0.120 |
Why?
|
Neutropenia | 1 | 2019 | 892 | 0.120 |
Why?
|
Pneumonia, Bacterial | 1 | 2017 | 320 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2019 | 863 | 0.110 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 452 | 0.110 |
Why?
|
Catheters, Indwelling | 1 | 1996 | 436 | 0.110 |
Why?
|
RNA, Bacterial | 2 | 2007 | 393 | 0.110 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 5 | 2006 | 142 | 0.110 |
Why?
|
Teicoplanin | 1 | 1993 | 27 | 0.110 |
Why?
|
Antimalarials | 1 | 2020 | 909 | 0.110 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2018 | 365 | 0.110 |
Why?
|
Drug Combinations | 2 | 2018 | 2089 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 583 | 0.110 |
Why?
|
Humans | 60 | 2021 | 768166 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 591 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 1996 | 537 | 0.090 |
Why?
|
Disease Outbreaks | 2 | 2017 | 1761 | 0.090 |
Why?
|
beta-Lactam Resistance | 4 | 2014 | 79 | 0.090 |
Why?
|
Exanthema | 1 | 2015 | 503 | 0.090 |
Why?
|
Klebsiella Infections | 2 | 2010 | 146 | 0.090 |
Why?
|
Penicillin-Binding Proteins | 2 | 2010 | 152 | 0.090 |
Why?
|
Virus Diseases | 1 | 2017 | 724 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 1014 | 0.090 |
Why?
|
Klebsiella | 1 | 2010 | 49 | 0.090 |
Why?
|
Recurrence | 3 | 2017 | 8509 | 0.080 |
Why?
|
Sulbactam | 2 | 2018 | 32 | 0.080 |
Why?
|
Middle Aged | 24 | 2020 | 223492 | 0.080 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1942 | 0.080 |
Why?
|
Ampicillin | 2 | 2018 | 137 | 0.080 |
Why?
|
Postpartum Period | 2 | 2013 | 1198 | 0.080 |
Why?
|
Acute Disease | 2 | 2017 | 7243 | 0.080 |
Why?
|
Molecular Sequence Data | 6 | 2002 | 17622 | 0.080 |
Why?
|
Male | 30 | 2020 | 364719 | 0.080 |
Why?
|
Mutation | 5 | 2007 | 30238 | 0.080 |
Why?
|
Oxacillin | 2 | 2014 | 41 | 0.080 |
Why?
|
Staphylococcal Skin Infections | 1 | 2009 | 78 | 0.080 |
Why?
|
Debridement | 1 | 2011 | 494 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1397 | 0.080 |
Why?
|
Virginiamycin | 2 | 1998 | 11 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 2009 | 122 | 0.080 |
Why?
|
Treponema pallidum | 1 | 2008 | 48 | 0.070 |
Why?
|
Soft Tissue Infections | 1 | 2009 | 168 | 0.070 |
Why?
|
Hospitals, Veterans | 3 | 2018 | 395 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2011 | 1049 | 0.070 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1240 | 0.070 |
Why?
|
Hospitals, Urban | 1 | 2009 | 497 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 556 | 0.070 |
Why?
|
Risk Factors | 13 | 2018 | 74944 | 0.070 |
Why?
|
Operon | 1 | 2007 | 371 | 0.070 |
Why?
|
Escherichia coli | 3 | 2004 | 4214 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1907 | 0.070 |
Why?
|
Glycopeptides | 2 | 2001 | 225 | 0.070 |
Why?
|
Hemolysin Proteins | 2 | 2006 | 113 | 0.060 |
Why?
|
Gene Deletion | 2 | 2004 | 2675 | 0.060 |
Why?
|
Cohort Studies | 6 | 2020 | 41754 | 0.060 |
Why?
|
Doxycycline | 1 | 2008 | 349 | 0.060 |
Why?
|
Carrier State | 1 | 2009 | 529 | 0.060 |
Why?
|
Hospitalization | 3 | 2020 | 10840 | 0.060 |
Why?
|
HIV Infections | 2 | 2009 | 17569 | 0.060 |
Why?
|
Female | 25 | 2020 | 397192 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13014 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 32 | 0.060 |
Why?
|
Aged | 17 | 2020 | 171504 | 0.060 |
Why?
|
Cephalosporin Resistance | 1 | 2004 | 17 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8542 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3626 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2004 | 775 | 0.050 |
Why?
|
Piperacillin | 1 | 2003 | 37 | 0.050 |
Why?
|
Ceftazidime | 1 | 2003 | 57 | 0.050 |
Why?
|
Escherichia coli Infections | 3 | 2004 | 524 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2003 | 41 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.050 |
Why?
|
Chromosomes, Bacterial | 1 | 2004 | 281 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2002 | 13421 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2019 | 81762 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1999 | 2748 | 0.050 |
Why?
|
Leukapheresis | 1 | 2003 | 150 | 0.050 |
Why?
|
Case-Control Studies | 9 | 2018 | 22291 | 0.050 |
Why?
|
Erythromycin | 2 | 2003 | 115 | 0.050 |
Why?
|
Ceftriaxone | 1 | 2003 | 175 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2004 | 253 | 0.050 |
Why?
|
Polymerase Chain Reaction | 4 | 2005 | 6082 | 0.050 |
Why?
|
Penicillin Resistance | 2 | 2004 | 77 | 0.050 |
Why?
|
Point Mutation | 2 | 2004 | 1596 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2006 | 408 | 0.050 |
Why?
|
Peptidyl Transferases | 1 | 2001 | 55 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2004 | 238 | 0.050 |
Why?
|
Hexosyltransferases | 1 | 2001 | 58 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2003 | 313 | 0.050 |
Why?
|
Molecular Epidemiology | 2 | 2004 | 473 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5458 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 188 | 0.050 |
Why?
|
Enterobacteriaceae Infections | 1 | 2003 | 190 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2002 | 766 | 0.050 |
Why?
|
Serratia marcescens | 1 | 2000 | 48 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.040 |
Why?
|
Methyltransferases | 1 | 2003 | 373 | 0.040 |
Why?
|
Primary Health Care | 1 | 2017 | 4746 | 0.040 |
Why?
|
Hemolysis | 1 | 2002 | 417 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5717 | 0.040 |
Why?
|
Administration, Oral | 1 | 2008 | 4030 | 0.040 |
Why?
|
Gene Dosage | 1 | 2004 | 1219 | 0.040 |
Why?
|
Laboratories, Hospital | 1 | 2001 | 192 | 0.040 |
Why?
|
Conjugation, Genetic | 2 | 2005 | 116 | 0.040 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1673 | 0.040 |
Why?
|
Carbapenems | 1 | 2000 | 125 | 0.040 |
Why?
|
Peptide Synthases | 1 | 1999 | 81 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24315 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2001 | 462 | 0.040 |
Why?
|
Base Sequence | 3 | 2002 | 12421 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2019 | 65371 | 0.040 |
Why?
|
Logistic Models | 4 | 2019 | 13290 | 0.040 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2018 | 168 | 0.040 |
Why?
|
Fetal Blood | 1 | 2004 | 1361 | 0.030 |
Why?
|
Metronidazole | 1 | 2018 | 236 | 0.030 |
Why?
|
Latex Fixation Tests | 2 | 2010 | 29 | 0.030 |
Why?
|
United States | 8 | 2021 | 73039 | 0.030 |
Why?
|
Gases | 1 | 2017 | 205 | 0.030 |
Why?
|
Young Adult | 4 | 2017 | 60066 | 0.030 |
Why?
|
Open Reading Frames | 1 | 1999 | 818 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1596 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 623 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1999 | 2179 | 0.030 |
Why?
|
DNA Primers | 1 | 1999 | 2828 | 0.030 |
Why?
|
Oxazoles | 1 | 1996 | 199 | 0.030 |
Why?
|
Adult | 10 | 2019 | 223646 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12077 | 0.030 |
Why?
|
Cefoxitin | 1 | 2014 | 36 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1918 | 0.030 |
Why?
|
Diarrhea | 1 | 2019 | 1320 | 0.030 |
Why?
|
Cephalosporins | 1 | 2014 | 200 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2017 | 594 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 542 | 0.030 |
Why?
|
Phenotype | 3 | 2004 | 16726 | 0.020 |
Why?
|
Quality Improvement | 2 | 2018 | 3857 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1993 | 1305 | 0.020 |
Why?
|
Assisted Circulation | 1 | 1971 | 100 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4620 | 0.020 |
Why?
|
Device Removal | 1 | 2016 | 643 | 0.020 |
Why?
|
Culture Media | 2 | 2004 | 898 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59629 | 0.020 |
Why?
|
Perioperative Care | 1 | 2018 | 1043 | 0.020 |
Why?
|
Time Factors | 4 | 2018 | 40218 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2003 | 3409 | 0.020 |
Why?
|
Intensive Care Units | 2 | 2001 | 3800 | 0.020 |
Why?
|
Infection Control | 1 | 1996 | 985 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2015 | 1321 | 0.020 |
Why?
|
Boston | 2 | 2018 | 9374 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 755 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 14164 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12543 | 0.020 |
Why?
|
Perineum | 1 | 2009 | 212 | 0.020 |
Why?
|
Novobiocin | 1 | 2007 | 33 | 0.020 |
Why?
|
Decision Making | 1 | 2001 | 3953 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2009 | 310 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3905 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3706 | 0.020 |
Why?
|
Aminoacyltransferases | 1 | 2007 | 52 | 0.020 |
Why?
|
Genotype | 1 | 2001 | 13045 | 0.020 |
Why?
|
Bacteriolysis | 1 | 2006 | 51 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 1971 | 711 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6611 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 2004 | 149 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6498 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2018 | 5349 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3288 | 0.010 |
Why?
|
Prospective Studies | 4 | 2017 | 54926 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6793 | 0.010 |
Why?
|
Incidence | 2 | 2018 | 21538 | 0.010 |
Why?
|
Risk-Taking | 1 | 2009 | 1023 | 0.010 |
Why?
|
Cell Culture Techniques | 2 | 2003 | 1667 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1951 | 0.010 |
Why?
|
Aorta | 1 | 1971 | 2045 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 939 | 0.010 |
Why?
|
Enterobacteriaceae | 1 | 2004 | 161 | 0.010 |
Why?
|
Breast | 1 | 2011 | 1976 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1743 | 0.010 |
Why?
|
Muramoylpentapeptide Carboxypeptidase | 1 | 2001 | 26 | 0.010 |
Why?
|
Carbon-Oxygen Ligases | 1 | 2001 | 4 | 0.010 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 263 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2001 | 79 | 0.010 |
Why?
|
Outpatients | 1 | 2009 | 1600 | 0.010 |
Why?
|
Virginia | 1 | 2001 | 115 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2009 | 1344 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15948 | 0.010 |
Why?
|
New England | 1 | 2004 | 1058 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14729 | 0.010 |
Why?
|
Blood Cells | 1 | 2003 | 309 | 0.010 |
Why?
|
Ampicillin Resistance | 1 | 2000 | 10 | 0.010 |
Why?
|
Pregnancy | 2 | 2013 | 30256 | 0.010 |
Why?
|
Health Care Costs | 1 | 2013 | 3239 | 0.010 |
Why?
|
Sequence Analysis | 1 | 2000 | 240 | 0.010 |
Why?
|
Signal Transduction | 1 | 2003 | 23645 | 0.010 |
Why?
|
Hydrolysis | 1 | 2000 | 646 | 0.010 |
Why?
|
Peritonitis | 1 | 2001 | 368 | 0.010 |
Why?
|
Hospitals, University | 1 | 2001 | 570 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13671 | 0.010 |
Why?
|
Virulence | 1 | 2002 | 1297 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2002 | 436 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2923 | 0.010 |
Why?
|
Drug Utilization | 1 | 2004 | 1189 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 2120 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 1430 | 0.010 |
Why?
|
Long-Term Care | 1 | 2001 | 631 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4580 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 1419 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1207 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1955 | 111 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1375 | 0.010 |
Why?
|
Hepatitis A | 1 | 1955 | 126 | 0.010 |
Why?
|
Feces | 1 | 2001 | 1511 | 0.010 |
Why?
|
Hepatitis | 1 | 1955 | 227 | 0.010 |
Why?
|
Cortisone | 1 | 1953 | 90 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15454 | 0.010 |
Why?
|
Usher Syndromes | 1 | 1953 | 56 | 0.010 |
Why?
|
Phylogeny | 1 | 2000 | 2843 | 0.010 |
Why?
|
Pemphigus | 1 | 1953 | 107 | 0.010 |
Why?
|
Odds Ratio | 1 | 2004 | 9669 | 0.010 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1953 | 619 | 0.010 |
Why?
|
Central Venous Pressure | 1 | 1971 | 80 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6229 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26422 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3402 | 0.010 |
Why?
|
Methods | 1 | 1971 | 1066 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1955 | 596 | 0.010 |
Why?
|
Cell Cycle | 1 | 1997 | 2932 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10590 | 0.000 |
Why?
|
Population Surveillance | 1 | 1999 | 2596 | 0.000 |
Why?
|
Dogs | 2 | 1971 | 3845 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2001 | 4937 | 0.000 |
Why?
|
Models, Theoretical | 1 | 2000 | 3573 | 0.000 |
Why?
|
Regional Blood Flow | 1 | 1971 | 1500 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1971 | 1375 | 0.000 |
Why?
|
Carotid Arteries | 1 | 1971 | 942 | 0.000 |
Why?
|
Sex Factors | 1 | 2000 | 10632 | 0.000 |
Why?
|
Phenytoin | 1 | 1965 | 189 | 0.000 |
Why?
|
Coronary Vessels | 2 | 1971 | 3124 | 0.000 |
Why?
|
Digoxin | 1 | 1965 | 246 | 0.000 |
Why?
|
Adolescent | 2 | 2004 | 89169 | 0.000 |
Why?
|
Animals | 4 | 2002 | 169246 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 2 | 1965 | 2258 | 0.000 |
Why?
|
Prevalence | 1 | 1999 | 15869 | 0.000 |
Why?
|
Hemodynamics | 1 | 1971 | 4194 | 0.000 |
Why?
|
Heart Rate | 1 | 1971 | 4214 | 0.000 |
Why?
|
Infant | 1 | 2001 | 36535 | 0.000 |
Why?
|
Electrocardiography | 1 | 1971 | 6412 | 0.000 |
Why?
|
Child, Preschool | 1 | 2001 | 42669 | 0.000 |
Why?
|
Kidney | 1 | 1971 | 7064 | 0.000 |
Why?
|
Blood Pressure | 1 | 1971 | 8543 | 0.000 |
Why?
|
Coronary Circulation | 1 | 1959 | 1617 | 0.000 |
Why?
|
Child | 1 | 2001 | 80917 | 0.000 |
Why?
|